BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8661807)

  • 1. Carcinoid tumors: development of our knowledge.
    Creutzfeldt W
    World J Surg; 1996 Feb; 20(2):126-31. PubMed ID: 8661807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical background and natural history of carcinoids.
    Creutzfeldt W
    Digestion; 1994; 55 Suppl 3():3-10. PubMed ID: 7698535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastrointestinal carcinoids and carcinoid syndrome: classification, diagnosis and therapy].
    Custureri F; Urciuoli P; Oddi A; D'Orazi V; Angelini R; Greco L; Maturo A; Grilli P; Tarroni D; Giordano R; Modesti M; Iavarone C
    G Chir; 1997 Oct; 18(10):514-20. PubMed ID: 9479955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of intestinal carcinoids.
    Angeletti S; Annibale B; Marignani M; Corleto VD; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S108-10. PubMed ID: 10604113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin.
    Jaffee IM; Rahmani M; Singhal MG; Younes M
    Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are goblet cell carcinoids a group of heterogeneous tumors?
    Macak J; Nemejcova K; Dvorackova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):281-285. PubMed ID: 28659644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
    Soga J
    J Exp Clin Cancer Res; 1998 Mar; 17(1):3-12. PubMed ID: 9646227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tumors of the gastrointestinal tract.
    Chejfec G; Falkmer S; Askensten U; Grimelius L; Gould VE
    Pathol Res Pract; 1988 Apr; 183(2):143-54. PubMed ID: 3290866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroendocrine products of intestinal carcinoids. An immunoperoxidase study of 35 carcinoid tumors stained for serotonin and eight polypeptide hormones.
    Yang K; Ulich T; Cheng L; Lewin KJ
    Cancer; 1983 May; 51(10):1918-26. PubMed ID: 6187428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumors of the gastrointestinal tract].
    Klöppel G
    Pathologe; 2003 Jul; 24(4):287-96. PubMed ID: 14513276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal carcinoid tumors: current management strategies.
    Memon MA; Nelson H
    Dis Colon Rectum; 1997 Sep; 40(9):1101-18. PubMed ID: 9293943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
    Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
    Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.